findmyKOL
Clinical trialNCT04396808Active, not recruitingInterventional

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

SponsorUniversity of Michigan Rogel Cancer CenterEnrollment805Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan, United States

  • Henry Ford Health System

    Detroit, Michigan, United States

  • Sherwood Medical Center

    Detroit, Michigan, United States

  • Spectrum Health Medical Group

    Grand Rapids, Michigan, United States

  • Western Michigan Urological Associates

    Holland, Michigan, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • University of North Carolina

    Chapel Hill, North Carolina, United States

  • University of Pennsylvania Perelman School of Medicine

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Nov 2020
Primary completion
31 Mar 2028
Completion
31 Mar 2031
Last update posted
15 Apr 2026
Registered enrollment
805
Registry id
NCT04396808

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.